Ligand profile
ZINC100309209
Virtual-screening candidate from ZINC.
Bound to: KP13_03545 — Cysteine synthase B
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC100309209- UniProt (similar protein)
P9WP55- Tanimoto
- 0.852
- Target protein
- KP13_03545
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 79.2
- −1 ≤ LogP ≤ 5 4.78
- MW ≤ 500 Da 461.3
- LogP ≤ 5 4.78
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 79.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCN1C(=O)/C(=C/c2ccc(OC)c(Br)c2)S/C1=N/c1cccc(C(=O)O)c1CCN1C(=O)/C(=C/c2ccc(OC)c(Br)c2)S/C1=N/c1cccc(C(=O)O)c1
InChI=1S/C20H17BrN2O4S/c1-3-23-18(24)17(10-12-7-8-16(27-2)15(21)9-12)28-20(23)22-14-6-4-5-13(11-14)19(25)26/h4-11H,3H2,1-2H3,(H,25,26)/b17-10-,22-20+InChI=1S/C20H17BrN2O4S/c1-3-23-18(24)17(10-12-7-8-16(27-2)15(21)9-12)28-20(23)22-14-6-4-5-13(11-14)19(25)26/h4-11H,3H2,1-2H3,(H,25,26)/b17-10-,22-20+
AXYSZBJGWPJPLR-LVVZJAEZSA-NAXYSZBJGWPJPLR-LVVZJAEZSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL2418505
- Homolog
- P9WP55
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC100309209 →
- ZINC ZINC20 ZINC100309209 →
- UniProt UniProt P9WP55 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC100309209”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03545.
PDB 8
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 15
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).